ArticleCell death & disease2018

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway.

Lihui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.